iRhythm Technologies (IRTC)
(Delayed Data from NSDQ)
$116.34 USD
+4.34 (3.88%)
Updated Apr 23, 2024 04:00 PM ET
After-Market: $116.33 -0.01 (-0.01%) 4:28 PM ET
3-Hold of 5 3
D Value B Growth F Momentum D VGM
Fundamental Charts
About Cash from Investing (Quarterly)
The company's quarterly Cash from Investing value is the sum of the company's current quarter cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
IRTC 116.34 +4.34(3.88%)
Will IRTC be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for IRTC based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for IRTC
iRhythm Technologies (IRTC) Surges 4.2%: Is This an Indication of Further Gains?
IRhythm Technologies (IRTC) Reports Q4 Loss, Tops Revenue Estimates
IRTC: What are Zacks experts saying now?
Zacks Private Portfolio Services
Inspire Medical Systems (INSP) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Down -23.87% in 4 Weeks, Here's Why iRhythm Technologies (IRTC) Looks Ripe for a Turnaround
IRhythm Technologies (IRTC) Expected to Beat Earnings Estimates: Should You Buy?
Other News for IRTC
Baron Health Care Fund Q1 2024 Shareholder Letter
iRhythm Technologies to Report First Quarter 2024 Financial Results on May 2, 2024
Needham sees BSX, CNMD, RMD beating Street, despite medtech slow down
Class Action Suit against iRhythm Technologies, Inc. (IRTC)
What's Driving LivaNova PLC's Surprising 11% Stock Rally?